Literature DB >> 7518760

A novel in vitro assay system for transendothelial tumor cell invasion: significance of E-selectin and alpha 3 integrin in the transendothelial invasion by HT1080 fibrosarcoma cells.

T Okada1, H Okuno, Y Mitsui.   

Abstract

The interaction of tumor cells with endothelial cells is a key event in tumor metastasis. We established an in vitro invasion assay system, in which the invasion of tumor cells after interaction with endothelial cells can be examined. Two chamber culture wells separated by porous membrane were used. Human umbilical vein endothelial cells (HUVEC) were placed on porous membranes coated with matrix components. The invasion by HT1080 fibrosarcoma cells was determined in this system by counting the number of cells that moved through the membranes from upper to lower chambers. HUVEC cells did not migrate through the membranes as judged by the staining with UEA-I. Observation by scanning electron microscopy revealed that HT1080 cells bound to HUVEC surfaces and migrated underneath the HUVEC monolayer. Effects of antibodies specific for cell surface adhesion molecules on the migration of HT1080 cells were examined. Invasion of uncoated membranes and membranes coated with HUVEC cells was compared. Antibody against E-selectin significantly suppressed an increase of HT1080 cell invasion of HUVEC monolayers stimulated by IL-1 beta or TNF alpha. Antibody against integrin alpha 3 subunit remarkably inhibited the invasion of HUVEC cell-coated membranes, suggesting that integrins with the alpha 3 subunit may play an important role in the transendothelial invasion by HT1080 cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518760     DOI: 10.1007/bf01753837

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  45 in total

Review 1.  Integrins and tumor invasion.

Authors:  S Dedhar
Journal:  Bioessays       Date:  1990-12       Impact factor: 4.345

2.  Identification of an inducible endothelial-leukocyte adhesion molecule.

Authors:  M P Bevilacqua; J S Pober; D L Mendrick; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma.

Authors:  S D Hoff; Y Matsushita; D M Ota; K R Cleary; T Yamori; S Hakomori; T Irimura
Journal:  Cancer Res       Date:  1989-12-15       Impact factor: 12.701

Review 4.  Metastatic tumor cell interactions with endothelium, basement membrane and tissue.

Authors:  G L Nicolson
Journal:  Curr Opin Cell Biol       Date:  1989-10       Impact factor: 8.382

5.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.

Authors:  M P Bevilacqua; S Stengelin; M A Gimbrone; B Seed
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

6.  Use of the Membrane Invasion Culture System (MICS) as a screen for anti-invasive agents.

Authors:  D R Welch; T J Lobl; E A Seftor; P J Wack; P A Aeed; K H Yohem; R E Seftor; M J Hendrix
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

7.  An inducible endothelial cell surface glycoprotein mediates melanoma adhesion.

Authors:  G E Rice; M P Bevilacqua
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

8.  Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues.

Authors:  G E Rice; J M Munro; C Corless; M P Bevilacqua
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

9.  ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex.

Authors:  M L Phillips; E Nudelman; F C Gaeta; M Perez; A K Singhal; S Hakomori; J C Paulson
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

Review 10.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

View more
  14 in total

1.  A modified Boyden chamber assay for tumor cell transendothelial migration in vitro.

Authors:  Y H Li; C Zhu
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Significance of VLA-4-VCAM-1 interaction and CD44 for transendothelial invasion in a bone marrow metastatic myeloma model.

Authors:  T Okada; R G Hawley; M Kodaka; H Okuno
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

3.  ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells.

Authors:  Justin M Drake; Garth Strohbehn; Thomas B Bair; Jessica G Moreland; Michael D Henry
Journal:  Mol Biol Cell       Date:  2009-02-18       Impact factor: 4.138

4.  The differential effect of endothelial cell factors on in vitro motility of malignant and non-malignant cells.

Authors:  Adele Wright; Yu-Hua Li; Cheng Zhu
Journal:  Ann Biomed Eng       Date:  2008-04-09       Impact factor: 3.934

5.  Enhancement of type IV collagenases by highly metastatic variants of HT1080 fibrosarcoma cells established by a transendothelial invasion system in vitro.

Authors:  T Okada; J Li; M Kodaka; H Okuno
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

6.  In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis.

Authors:  Rachel A Davidowitz; Marcin P Iwanicki; Joan S Brugge
Journal:  J Vis Exp       Date:  2012-02-17       Impact factor: 1.355

7.  A critical role for tetraspanin CD151 in alpha3beta1 and alpha6beta4 integrin-dependent tumor cell functions on laminin-5.

Authors:  Nicole E Winterwood; Afshin Varzavand; Marit N Meland; Leonie K Ashman; Christopher S Stipp
Journal:  Mol Biol Cell       Date:  2006-03-29       Impact factor: 4.138

8.  Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cells.

Authors:  Shoumin Zhu; Jun Hong; Manish K Tripathi; Vikas Sehdev; Abbes Belkhiri; Wael El-Rifai
Journal:  Mol Cancer Res       Date:  2012-11-16       Impact factor: 5.852

9.  Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

Authors:  T Yoneda; A Sasaki; C Dunstan; P J Williams; F Bauss; Y A De Clerck; G R Mundy
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

10.  PKCε Is an Essential Mediator of Prostate Cancer Bone Metastasis.

Authors:  Alvaro Gutierrez-Uzquiza; Cynthia Lopez-Haber; Danielle L Jernigan; Alessandro Fatatis; Marcelo G Kazanietz
Journal:  Mol Cancer Res       Date:  2015-05-28       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.